These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2696694)

  • 21. Institutional experience with clofarabine and cytarabine in relapsed pediatric acute myeloid leukemia.
    Moreno L; Fernandez-Navarro JM; Del Mar Andres M; Bautista F; Tasso M; Verdeguer A
    J Pediatr Hematol Oncol; 2012 Jan; 34(1):e17-21. PubMed ID: 21716139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.
    Ziogas DC; Voulgarelis M; Zintzaras E
    Clin Ther; 2011 Mar; 33(3):254-79. PubMed ID: 21600383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary results of intensive care of acute myeloid leukemia in children under 2 therapeutic protocols].
    Cáp J; Foltinová A; Misíková Z
    Cesk Pediatr; 1984 Sep; 39(9):509-12. PubMed ID: 6595070
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol].
    Popa AV; Maiakova SA; Kurmashov VI
    Vopr Onkol; 1997; 43(4):414-7. PubMed ID: 9381692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of childhood acute nonlymphocytic leukemia with high-dose cytosine arabinoside, 6-thioguanine, and doxorubicin without maintenance therapy: pilot study ANLL-80 of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; Hhlen K; Colly LP; Vossen JM
    Pediatr Hematol Oncol; 1988; 5(2):93-102. PubMed ID: 3152962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
    Steinherz PG; Shukla N; Kobos R; Steinherz L
    Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topotecan exposure estimation in pediatric acute myeloid leukemia supported by LC-MS-based drug monitoring and pharmacokinetic analysis.
    Bączek T; Konieczna L; Belka M; Maciejka-Kapuścińska L; Wiśniewski J; Niedźwiecki M; Balcerska A; Adamkiewicz-Drożyńska E; Wachowiak J
    J Pharm Biomed Anal; 2012 Nov; 70():330-6. PubMed ID: 22658903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a pilot study for the treatment of childhood acute nonlymphoblastic leukemia.
    Vowels MR; White L; Hughes DO
    Cancer; 1985 May; 55(10):2337-41. PubMed ID: 3838696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
    Quarello P; Berger M; Rivetti E; Galletto C; Masetti R; Manicone R; Barisone E; Pession A; Fagioli F
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):208-16. PubMed ID: 22395219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [State-of-the-art chemotherapy for acute myeloid leukemia].
    Miyawaki S
    Rinsho Ketsueki; 2012 Jan; 53(1):39-50. PubMed ID: 22374524
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement.
    Hiçsönmez G; Ozsoylu S; Tuncer M; Erer B
    Turk J Pediatr; 1988; 30(3):181-3. PubMed ID: 3242191
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
    Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M
    Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study.
    Moritake H; Tanaka S; Nakayama H; Miyamura T; Iwamoto S; Shimada A; Terui K; Saito A; Shiba N; Hayashi Y; Tomizawa D; Taga T; Goto H; Hasegawa D; Horibe K; Mizutani S; Adachi S
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28233452
    [No Abstract]   [Full Text] [Related]  

  • 35. Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
    Hiddemann W; Aul HC; Maschmeyer G; Urbanitz D; Lathan B; Reichle A; Köppler H; Donhuijsen-Ant R; Ludwig WD; Grüneisen T
    Haematol Blood Transfus; 1990; 33():604-10. PubMed ID: 2182450
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
    Khattab TM; Atra AA; Elimam NA; Kassar A; Zayed A; Baothman A
    Saudi Med J; 2008 May; 29(5):776-7. PubMed ID: 18454233
    [No Abstract]   [Full Text] [Related]  

  • 37. Intensive sequential chemotherapy for children with acute myelogenous leukemia.
    Grier HE; Gelber RD; Clavell LA; Camitta BM; Link MP; Garcea MJ; Weinstein HJ
    Haematol Blood Transfus; 1990; 33():193-7. PubMed ID: 2182411
    [No Abstract]   [Full Text] [Related]  

  • 38. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
    Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
    Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher urinary excretion of inorganic phosphate during early induction chemotherapy predicts a good prognosis in childhood acute leukemia.
    Ichikawa M; Kobayashi R; Nakajima M; Inamoto J; Suzuki D; Cho Y; Kaneda M; Yoshida M; Ariga T
    J Pediatr Hematol Oncol; 2011 May; 33(4):e143-8. PubMed ID: 21423043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytine.
    Leblanc T; Deméocq F; Leverger G; Baruchel A; Lemerle S; Vannier JP; Nelken B; Guillot T; Schaison G
    Med Pediatr Oncol; 1994; 22(2):119-24. PubMed ID: 8259097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.